Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,979,384
+$694,676 QoQ
Shares Held
2,484
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#2,136
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WILKINS INVESTMENT COUNSEL INC holds $77,139,543 across 7 Drug Manufacturers - General names. LLY ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
244,471 | $31,414,523 | |
| 2 | NVS |
Novartis AG
|
111,067 | $17,406,420 | |
| 3 | JNJ |
Johnson & Johnson
|
66,797 | $16,964,434 | |
| 4 | PFE |
Pfizer Inc
|
176,761 | $4,256,404 | |
| 5 | ABBV |
AbbVie Inc.
|
14,832 | $3,732,324 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
2,484 | $2,979,384 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,700 | $386,054 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,979,384 | 2,484 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,284,708 | 2,484 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,970,415 | 2,764 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,168,446 | 2,842 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $2,243,487 | 2,878 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,633,001 | 3,188 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,816,256 | 3,648 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,696,801 | 3,044 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,810,299 | 3,104 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,228,077 | 2,864 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $570,095 | 978 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $537,130 | 1,000 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $642,502 | 1,370 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $532,301 | 1,550 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $603,636 | 1,650 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $533,527 | 1,650 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $632,248 | 1,950 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $558,421 | 1,950 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $566,251 | 2,050 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $473,652 | 2,050 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $573,800 | 2,500 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $467,050 | 2,500 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $422,100 | 2,500 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $370,050 | 2,500 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $410,450 | 2,500 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $360,672 | 2,600 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||